Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-STEMI: Recombinant Streptokinase + pPCI in STEMI
NCT07875179Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant streptokinase in ST elevation myocardial infarction (STEMI), sponsored by The Affiliated Hospital of Xuzhou Medical University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
recombinant streptokinase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT07875179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07875179.